VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Trends Analyst Outlook Journalist POV

23 hedge funds and large institutions have $4.3M invested in Viridian Therapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

75% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 12

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$125K
2
+$42K
3
+$25K

Top Sellers

1
-$707K
2
-$150K
3
-$109K
4
Millennium Management
Millennium Management
New York
-$106K
5
Invesco
Invesco
Georgia
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.51M
2
$1.39M
3
$312K
4
$223K
5
$199K
6
$153K
7
$139K
8
$86K
9
$74K
10
$48K
11
$42K
12
$28K
13
$26K
14
$25K
15
$22K
16
$10K
17
$8K
18
$6K
19
$1K
20
$1K
21
$74
22
–
23
–
24
–
25
–
1
2